Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Caldas

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Oncogene|September 27, 2006
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancersS-F Chin, Y Wang, N P Thorne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2017
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trialH R Ali, A Dariush, J Thomas, et al.
British Journal of Cancer|July 29, 2010
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedS-J Dawson, N Makretsov, F M Blows, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis TrialH M Earl, L Hiller, J A Dunn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2026
Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathologyT Cantore, D-T Hoang, L R Pal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsH R Ali, E Provenzano, S-J Dawson, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical TrialCarolina T Macedo, Ticiana F Larocca, Márcia Noya-Rabelo, et al.
Journal of Medical Genetics|December 14, 1999
Familial gastric cancer: overview and guidelines for managementC Caldas, F Carneiro, H T Lynch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
Journal of Dental Research|March 23, 2023
Unequal Impact of <i>COL1A1</i> and <i>COL1A2</i> Variants on Dentinogenesis ImperfectaP M Yamaguti, M de La Dure-Molla, S Monnot, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Oncogene|September 27, 2006
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancersS-F Chin, Y Wang, N P Thorne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2017
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trialH R Ali, A Dariush, J Thomas, et al.
British Journal of Cancer|July 29, 2010
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedS-J Dawson, N Makretsov, F M Blows, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis TrialH M Earl, L Hiller, J A Dunn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2026
Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathologyT Cantore, D-T Hoang, L R Pal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsH R Ali, E Provenzano, S-J Dawson, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical TrialCarolina T Macedo, Ticiana F Larocca, Márcia Noya-Rabelo, et al.
Journal of Medical Genetics|December 14, 1999
Familial gastric cancer: overview and guidelines for managementC Caldas, F Carneiro, H T Lynch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
Journal of Dental Research|March 23, 2023
Unequal Impact of <i>COL1A1</i> and <i>COL1A2</i> Variants on Dentinogenesis ImperfectaP M Yamaguti, M de La Dure-Molla, S Monnot, et al.
Pageof 18